While GLP-1 receptor agonists have transformed metabolic care, they don’t address why GLP-1 signaling becomes impaired in the first place.
This session begins with a concise overview of endogenous GLP-1 physiology, highlighting the role of the gut, nutrient signaling, and metabolic health in incretin function. We then focus on how to support patients using—or considering—GLP-1 therapies through targeted lifestyle, nutrition, and microbiome strategies.
Learn how to:
• Enhance natural GLP-1 signaling
• Identify barriers to satiety and glycemic control
• Support patients experiencing common challenges on GLP-1 therapies
• Integrate functional strategies alongside conventional care
• deal for clinicians looking to expand their metabolic toolkit beyond medications.
Speaker: Melody Hartzler, PharmD, BCACP, BC-ADM, ABAAHP